Peer-reviewed data shows Gilead's drug effective against COVID-19 -NIH
May 22, 2020 at 18:34 PM EDT
The National Institutes of Health (NIH) said on Friday peer-reviewed data published in the New England Journal of Medicine from a trial testing Gilead Sciences Inc's remdesivir showed the drug was superior to the standard of care for COVID-19.